Status:
UNKNOWN
Cryobiopsy for Suspected Malignant Peripheral Lymphadenopathy
Lead Sponsor:
San Antonio Uniformed Services Health Education Consortium
Conditions:
Cryobiopsy of Peripheral Lymph Nodes
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
Cryobiopsy of peripheral lymph nodes with suspected malignant potential with comparison to standard core needle biopsy.
Detailed Description
Peripheral lymph node biopsy has long been accomplished to establish malignant and non-malignant diagnoses of lymphadenopathy. For several decades patients have undergone fine needle aspiration (FNA) ...
Eligibility Criteria
Inclusion
- Age 18-89
- Suspected or confirmed malignancy with suspected involvement of peripheral lymph nodes based on CT, PET-CT or ultrasound imaging with a clinical need for additional tissue or staging by tissue sampling
Exclusion
- Age \<18 or \>89
- Patient preference
- Severe allergy to lidocaine precluding use
- Severe allergy to chlorhexidine precluding use
- Overlying Infection
- Active anticoagulation or anti-platelet therapy, with the exception of aspirin mono-therapy, that cannot be safely held as determined by the performing or prescribing physician.
- Major organs, vasculature or tissue that would preclude the safety of the procedure as determined by the performing physician.
- Inability to reach the lymph node through a core needle introducer sheath as determined by the performing physician.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
490 Patients enrolled
Trial Details
Trial ID
NCT06120829
Start Date
December 1 2023
End Date
December 1 2025
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brooke Army Medical Center
Fort Sam Houston, Texas, United States, 78234